Deepak Nitrite Limited — Investor Meet, 03-06-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Deepak Nitrite reported FY25 consolidated revenue of INR 8,366 Cr (+8% YoY), with stable EBITDA at INR 1,176 Cr and PAT of INR 697 Cr despite pricing pressure. Q4 saw sharp sequential gains: revenue +14% to INR 2,202 Cr, EBITDA +79% to INR 339 Cr, and PAT doubling to INR 202 Cr, driven by capacity expansion and efficiency. Advanced Intermediates revenue rose 19% QoQ to INR 654 Cr but declined 7% YoY; Phenolics grew 16% YoY to INR 5,805 Cr. Management is expanding higher-value specialty products with low capex, focusing on pharma and personal care, plus major projects including a nitric acid plant and R&D center (INR 100 Cr). FY26 capex target is INR 1,200-1,500 Cr amid a larger INR 8,500 Cr expansion plan. The company aims for 60-70% renewable energy use and 60% lower carbon emissions by FY26 end. Margins face short-term volatility but outlook is cautiously optimistic, supported by domestic demand and integration. Dividend stands at INR 7.5/share (375%).